Carla Landolfi, ERT, Angelini - Qepler Summits And Conferences

Carla Landolfi, ERT

European Registered Toxicologist (ERT) R&D, Head of WEP Toxicology - Preclinical Development
Pomezia, Italy
Angelini is an international group leader in the healthcare and wellbeing market in the pharmaceutical and mass-market sectors

About 20 years of experience in toxicology field in the pharmaceutical industry.

Currently Head of Well Established Products Toxicology at Angelini, an Italian mid-size Pharmaceutical Company.

Experience in safety programs for pharmaceuticals, cosmetics, medical devices, biocides and other consumer products.

Experience in REACH, Toxicological Risk Assessment, Environmental Risk Assessment; occupational toxicology. Main or co-author of several papers and posters, published in peer-reviewed journals or presented at International Congresses.

Related Sessions:

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 11 April 2019
CASE STUDY: ICH Q3D: safety assessment of elemental impurities in topical drugs. The challange in defining the appropriate scenario of exposure.
  • What are elemental impurities
  • Establishing Permitted Daily Exposures for topical products
    • Focus on the mucosal route
  • Defining the appropriate scenario of exposures to set Analytical Limits
  • Case studies will be presented
View Details

2nd Annual Genotoxic Impurities in
Pharmaceuticals Summit 2021

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 15 Jul 2021
  • Virtual,
  • Pharma
Day 2: Friday, 16 July 2021
CASE STUDY: From in silico to in vivo assessment for mutagenicity of impurities.
  • From the literature to in silico analyses.
  • How to address positive AMES results.
  • In vivo genotoxicity testing strategies.
View Details